Aligos Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.About ALGS
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH).
ALGS Key Statistics
Stock Snapshot
With a market cap of 35.09M, Aligos Therapeutics(ALGS) trades at $5.67. The stock has a price-to-earnings ratio of -0.64.
On 2026-07-05, Aligos Therapeutics(ALGS) stock moved within a range of $5.35 to $5.70. With shares now at $5.67, the stock is trading +6.0% above its intraday low and -0.5% below the session's peak.
Trading volume for Aligos Therapeutics(ALGS) stock has reached 90.1K, versus its average volume of 65.27K.
The stock's 52-week range extends from a low of $4.80 to a high of $13.69.
The stock's 52-week range extends from a low of $4.80 to a high of $13.69.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.